Prediction of recurrent events by d-dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) study

American Heart Journal

Volumn 145, Issue 6, 2003, Pages 986-992

  Menown, Ian B A ^a   Mathew, Thomas P ^a   Gracey, Helen M ^a   Nesbitt, G Selby ^a   Murray, Pamela ^a   Young, Ian S ^a   Adgey, A A Jennifer ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARDIAC TROPONIN 1; CREATINE KINASE MB; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PADGEM PROTEIN; TROPONIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CREATINE KINASE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; ISOENZYME; TROPONIN I; TROPONIN T;

ARTICLE; BLOOD LEVEL; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; ST SEGMENT DEPRESSION; THORAX PAIN; ANALYSIS OF VARIANCE; BLOOD; RISK; RISK ASSESSMENT;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE, MB FORM; E-SELECTIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; ODDS RATIO; P-SELECTIN; RECURRENCE; RISK ASSESSMENT; TROPONIN I; TROPONIN T; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037783435     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00169-8     Document Type: Article

References (35)

1. Antman EM, Tanasijevic M J, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
2. Mathew TP, Menown IBA, Smith B, et al. Diagnosis and risk stratification of patients with anginal pain and non-diagnostic electrocardiograms. Q J Med 1999;92:565-71.
3. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000; 36:1812-7.
4. Heeschen C, Hamm CW, Goldmann B, et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757-62.
5. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
6. Mathew TP, Menown IBA, Adgey AAJ. Optimising classification of acute myocardial infarction: from diagnosis to prognosis. Eur Heart J 1999;20:1446-8.
7. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
8. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
9. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
10. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
11. Wallen NH, Held C, Rehnqvist N, et al. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J 1999;20:1039-43.
12. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001;103:491-5.
13. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997;96:4219-25.
14. Montalescot G, Collet JP, Choussat R, et al. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J 1998;19(Suppl H):H11-7.
15. Ma J, Hennekens CH, Ridker PM, et al. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol 1999;33:1347-52.
16. Danesh J, Whincup P, Walker M, et al. Fibrin d-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001;103:2323-7.
17. Mulvihill NT, Foley JB, Murphy R, et al. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 2000;36:1210-6.
18. Mulvihill NT, Foley JB, Murphy RT, et al. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 2001;85:623-7.
19. O'Malley T, Ludlam CA, Riemermsa RA, et al. Early increase in levels of soluble inter-cellular adhesion molecule-1 (slCAM-1): potential risk factor for the acute coronary syndromes. Eur Heart J 2001;22:1226-34.
20. Blankenberg S, Rupprecht HJ, Bickel C, et al, for the AtheroGene Investigators. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.
21. Hollander JE, Muttreja MR, Dalesandro MR, et al. Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol 1999;34:95-105.
22. Bayes-Genis A, Mateo J, Santalo M, et al. d-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J 2000;140:379-84.
23. Bhatia VK, Haskard DO. Markers of inflammation in unstable angina. Heart 2001;85:603-4.
24. Malik IS, Haskard DO. Soluble adhesion molecules in ischaemic heart disease. Eur Heart J 1999;20:990-1.
25. Newby LK. Cardiac marker testing: where should we focus? Am Heart J 2000;140:351-3.
26. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 2002;317:1-15.
27. Best PJ, Gersh BJ. Cell adhesion molecules and inflammation in acute coronary syndromes: markers and emerging risk factors. Eur Heart J 2001;22:1155-9.
28. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517-22.
29. de Lemos JA, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 2000;36:423-6.
30. Galvani M, Ferrini D, Ottani F, et al. Soluble E-selectin is not a marker of unstable coronary plaque in serum of patients with ischemic heart disease. J Thromb Thrombolysis 2000;9:53-60.
31. Ridker PM, Hennekens CH, Cerskus A, et al. Plasma concentration of cross-linked fibrin degradation product (d-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-40.
32. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001; 286:2405-12.
33. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf.
34. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999;100:1148-50.
35. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65.